AAstraZeneca Read More FDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapyJune 1, 2026 AstraZeneca has received approval from the US Food and Drug Administration (FDA) for Imfinzi (durvalumab) in combination with…
AAstraZeneca Read More FDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapyJune 1, 2026 AstraZeneca has received approval from the US Food and Drug Administration (FDA) for Imfinzi (durvalumab) in combination with…
AAstraZeneca Read More AstraZeneca’s Imfinzi Gets US FDA Nod for Bladder Cancer Combo TherapyMay 29, 2026 MT Newswires -Shutterstock The US Food and Drug Administration approved AstraZeneca’s (AZN.L, AZN,ST) Imfinzi, or durvalumab, in combination…